Risedronate Sodium Tablet, Film Coated
Product Images NDC 60505-3097

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Risedronate Sodium (NDC 60505-3097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Risedronatefig3 (Figure3)

FDA Label Image

Risedronatefig4 (Figure4)

FDA Label Image

Risedronatefig5 (Figure5)

FDA Label Image

Risedronatefig6 (Figure6)

FDA Label Image

Rise150mgblscarton1tab (Rise150mgblscarton1tab)

FDA Label Image

Rise35mgblscarton4tabs (Rise35mgblscarton4tabs)

This text is a set of instructions for taking Risedronate Sodium Tablets. It includes dosing instructions, warnings, and information on how to take the medication with food and other medications. The text also includes information about the medication's ingredients and storage instructions. It concludes by advising pharmacists to give each patient a medication guide.*

FDA Label Image

Rise75mg2s (Rise75mgblscarton2tabs)

FDA Label Image

Risedronatestructure (Risedronatechemstructure)

FDA Label Image

Risedronatefig1 (Risedronatefig1)

FDA Label Image

Risedronatefig2 (Risedronatefig2)

The text seems to be a chart or a graph description showing changes in bone mineral density from a two-year prevention study, with different measures for lumbar spine, femoral neck and trochanter. The description provides numerical data, but no additional information is given.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.